Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03434652 · ClinicalTrials.gov registry record · NA
Auricular Neurostimulation for Cyclic Vomiting Syndrome
A NA study of Cyclic Vomiting Syndrome and Abdominal Migraine, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT03434652: Completed NA study of Cyclic Vomiting Syndrome and Abdominal Migraine, sponsored by Medical College of Wisconsin.
NCT03434652 is a NA study of Cyclic Vomiting Syndrome and Abdominal Migraine that has completed, run by Medical College of Wisconsin. The registered enrollment target is 47 participants, below the 117-participant average among 3 other Cyclic Vomiting Syndrome trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03434652, a NA study of Cyclic Vomiting Syndrome and Abdominal Migraine, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the efficacy of auricular neurostimulation via an non-invasive percutaneous electrical nerve field stimulator in children and adults with cyclic vomiting syndrome.
Primary Outcome
Acute therapy arm: Daily nausea and vomiting severity assessed by validated scale 0-32 (0=no symptoms; 32=worse possible nausea/vomiting) with higher scores indicating worse outcomes (greater nausea/vomiting). Daily scores for baseline (day 1) and end of therapy (day 7) were compared for both active and sham groups. Chronic therapy arm: Daily nausea and vomiting severity assessed by validated scale 0-32 (0=no symptoms; 32=worse possible nausea/vomiting) with higher scores indicating worse outco
Conditions Studied
Interventions
- DEVICE Percutaneous neurostimulation
Study Locations (1)
Wisconsin
- Children's Hospital of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-01-31 |
| Est. Completion | 2021-03-03 |
| Phase | NA |
What the finished NCT03434652 record still lists
NCT03434652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 117-participant average among 3 other Cyclic Vomiting Syndrome trials with a reported enrollment target (60% lower).
The record links to 2 conditions, with Cyclic Vomiting Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Percutaneous neurostimulation is the first listed.
NCT03434652 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03434652 about?
NCT03434652 is a clinical study titled "Auricular Neurostimulation for Cyclic Vomiting Syndrome". This study evaluates the efficacy of auricular neurostimulation via an non-invasive percutaneous electrical nerve field stimulator in children and adults with cyclic vomiting syndrome.
What is the current status of trial NCT03434652?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2018-01-31. Estimated completion is 2021-03-03.
What conditions does trial NCT03434652 study?
This clinical trial studies the following conditions: Cyclic Vomiting Syndrome, Abdominal Migraine.
What interventions are being tested in trial NCT03434652?
The interventions under investigation include: Percutaneous neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT03434652?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03434652 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cyclic Vomiting Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI